Primecap Management CO Wave Life Sciences Ltd. Transaction History

Primecap Management CO

$134 Billion
Q3 2024

A detailed history of Primecap Management CO transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Primecap Management CO holds 2,580,700 shares of WVE stock, worth $34.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,580,700

Previous 2,664,216 3.13%

Holding current value

$34.9 Million

Previous $13.3 Million 59.18%

% of portfolio

0.02%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$5.12 - $9.01 $427,601 - $752,479	-83,516 Reduced 3.13%	2,580,700 $21.2 Million
Q2 2024 Aug 09, 2024	SELL	$4.38 - $6.48 $929,541 - $1.38 Million	-212,224 Reduced 7.38%	2,664,216 $13.3 Million
Q1 2024 May 13, 2024	SELL	$3.54 - $6.84 $3.13 Million - $6.04 Million	-882,968 Reduced 23.49%	2,876,440 $17.7 Million
Q4 2023 Feb 09, 2024	SELL	$4.16 - $6.87 $87,776 - $144,957	-21,100 Reduced 0.56%	3,759,408 $19 Million
Q3 2023 Nov 13, 2023	SELL	$3.56 - $5.75 $110,004 - $177,675	-30,900 Reduced 0.81%	3,780,508 $21.7 Million
Q2 2023 Aug 11, 2023	SELL	$3.51 - $4.69 $1.3 Million - $1.73 Million	-369,700 Reduced 8.84%	3,811,408 $13.9 Million
Q1 2023 May 15, 2023	SELL	$3.58 - $6.3 $30,430 - $53,550	-8,500 Reduced 0.2%	4,181,108 $18.1 Million
Q4 2022 Feb 13, 2023	SELL	$3.18 - $7.0 $700,554 - $1.54 Million	-220,300 Reduced 5.0%	4,189,608 $29.3 Million
Q3 2022 Nov 14, 2022	SELL	$2.37 - $4.28 $40,053 - $72,332	-16,900 Reduced 0.38%	4,409,908 $15.9 Million
Q2 2022 Aug 11, 2022	SELL	$1.23 - $3.25 $165,394 - $437,017	-134,467 Reduced 2.95%	4,426,808 $14.4 Million
Q1 2022 May 11, 2022	SELL	$2.0 - $3.28 $66,600 - $109,224	-33,300 Reduced 0.72%	4,561,275 $9.12 Million
Q4 2021 Feb 11, 2022	BUY	$3.14 - $5.15 $80,384 - $131,840	25,600 Added 0.56%	4,594,575 $14.4 Million
Q3 2021 Nov 12, 2021	SELL	$4.89 - $7.12 $90,909 - $132,367	-18,591 Reduced 0.41%	4,568,975 $22.4 Million
Q2 2021 Aug 10, 2021	SELL	$5.65 - $7.47 $442,869 - $585,528	-78,384 Reduced 1.68%	4,587,566 $30.6 Million
Q1 2021 May 14, 2021	BUY	$5.61 - $12.01 $4.16 Million - $8.91 Million	741,475 Added 18.89%	4,665,950 $26.2 Million
Q4 2020 Feb 08, 2021	BUY	$6.99 - $9.26 $4.36 Million - $5.77 Million	623,080 Added 18.87%	3,924,475 $30.9 Million
Q3 2020 Nov 13, 2020	BUY	$8.49 - $19.54 $16.9 Million - $38.8 Million	1,985,241 Added 150.84%	3,301,395 $28 Million
Q2 2020 Aug 13, 2020	BUY	$7.44 - $11.29 $599,411 - $909,590	80,566 Added 6.52%	1,316,154 $13.7 Million
Q1 2020 May 14, 2020	SELL	$6.94 - $14.22 $403,436 - $826,637	-58,132 Reduced 4.49%	1,235,588 $11.6 Million
Q4 2019 Feb 14, 2020	BUY	$7.99 - $37.6 $3.71 Million - $17.5 Million	464,219 Added 55.96%	1,293,720 $10.4 Million
Q3 2019 Nov 13, 2019	BUY	$19.17 - $27.4 $15.9 Million - $22.7 Million	829,501 New	829,501 $17 Million

Others Institutions Holding WVE

# of Institutions

164

Shares Held

117M

Call Options Held

148K

Put Options Held

109K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.17B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Account

Primecap Management CO Wave Life Sciences Ltd. Transaction History